{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:16Z","timestamp":1786372876573,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2016B030231001"],"award-info":[{"award-number":["2016B030231001"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2017B020230002"],"award-info":[{"award-number":["2017B020230002"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2014AA020702"],"award-info":[{"award-number":["2014AA020702"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.intimp.2018.04.011","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T19:08:02Z","timestamp":1523387282000},"page":"127-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Rescue of iCIKs transfer from PD-1\/PD-L1 immune inhibition in patients with resectable tongue squamous cell carcinoma (TSCC)"],"prefix":"10.1016","volume":"59","author":[{"given":"Xiaofeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2018.04.011_bb0005","first-page":"212","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.intimp.2018.04.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053415","article-title":"Survival of patients with oral cavity cancer in Germany","volume":"8","author":"Listl","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2018.04.011_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00106-016-0137-7","article-title":"Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck","volume":"64","author":"Mandapathil","year":"2016","journal-title":"HNO"},{"key":"10.1016\/j.intimp.2018.04.011_bb0020","first-page":"10","article-title":"Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients","volume":"8","author":"Bose","year":"2008","journal-title":"Cancer Immun."},{"issue":"7","key":"10.1016\/j.intimp.2018.04.011_bb0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2018.04.011_bb0030","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.5301\/jbm.5000170","article-title":"PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer","volume":"30","author":"Cheng","year":"2015","journal-title":"Int. J. Biol. Markers"},{"issue":"11","key":"10.1016\/j.intimp.2018.04.011_bb0035","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.18632\/oncotarget.7593","article-title":"CD274\/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity","volume":"7","author":"Straub","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.intimp.2018.04.011_bb0040","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2018.04.011_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbmt.2004.11.019","article-title":"A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma","volume":"11","author":"Leemhuis","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.intimp.2018.04.011_bb0050","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archotol.126.10.1225","article-title":"Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study","volume":"126","author":"To","year":"2000","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"10","key":"10.1016\/j.intimp.2018.04.011_bb0055","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00262-013-1465-z","article-title":"Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer","volume":"62","author":"Zhu","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.intimp.2018.04.011_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.intimp.2015.05.042","article-title":"Adoptive cell transfer after chemotherapy enhances survival in patients with resectable HNSCC","volume":"28","author":"Jiang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2018.04.011_bb0065","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"4\u20135","key":"10.1016\/j.intimp.2018.04.011_bb0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer - surgery","volume":"45","author":"Shah","year":"2009","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2018.04.011_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hed.24589","article-title":"Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study","volume":"39","author":"Ng","year":"2017","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.intimp.2018.04.011_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9208","key":"10.1016\/j.intimp.2018.04.011_bb0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2018.04.011_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181837276","article-title":"Suppressive influences in the immune response to cancer","volume":"32","author":"Bronte","year":"2009","journal-title":"J. Immunother."},{"issue":"5","key":"10.1016\/j.intimp.2018.04.011_bb0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc1613","article-title":"Immunotherapy and chemotherapy\u2013a practical partnership","volume":"5","author":"Lake","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2018.04.011_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/emm.2004.2","article-title":"Serum concentrations of soluble 4-1BB and 4-BB ligand correlated with the disease severity in rheumatoid arthritis","volume":"36","author":"Jung","year":"2004","journal-title":"Exp. Mol. Med."},{"issue":"13","key":"10.1016\/j.intimp.2018.04.011_bb0105","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.molimm.2008.05.014","article-title":"Interaction of human PD-L1 and B7-1","volume":"45","author":"Butte","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2018.04.011_bb0110","first-page":"70","article-title":"Impact of surgical intervention on the immune processes in organism","volume":"6","author":"Stasenko","year":"2014","journal-title":"Klin. Khir."},{"issue":"2","key":"10.1016\/j.intimp.2018.04.011_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"Topalian","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2018.04.011_bb0120","first-page":"6501","article-title":"B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma","volume":"63","author":"Strome","year":"2003","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2018.04.011_bb0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00262-016-1815-8","article-title":"Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts","volume":"65","author":"Poh","year":"2016","journal-title":"Cancer Immunol. Immunother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918301553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918301553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:10:36Z","timestamp":1761585036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918301553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":25,"alternative-id":["S1567576918301553"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.04.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue of iCIKs transfer from PD-1\/PD-L1 immune inhibition in patients with resectable tongue squamous cell carcinoma (TSCC)","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}